Reviews

New fibrinolytic agents for MI: As effective as current agents, but easier to administer

Author and Disclosure Information

ABSTRACTThe efficacy and safety of fibrinolytic agents have not dramatically changed since alteplase (Activase), a derivative of tissue plasminogen activator (t-PA), was introduced nearly 2 decades ago. However, newer agents have a longer half-life, making them easier to deliver. Fibrinolytic therapy is underused in many patients, especially in those traditionally thought to be at high risk for complications.


 

Next Article: